Your browser doesn't support javascript.
loading
Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment.
Shi, Ke; Liu, Yao; Zhang, Qun; Ran, Chong-Ping; Hou, Jie; Zhang, Yi; Wang, Xian-Bo.
Afiliación
  • Shi K; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Liu Y; Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China.
  • Zhang Q; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Ran CP; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Hou J; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Zhang Y; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Wang XB; Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China.
Chin J Integr Med ; 28(1): 3-11, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34962616
ABSTRACT
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, is a major public health issue. The epidemic is unlikely to be contained until the global launch of safe and effective vaccines that could prevent serious illnesses and provide herd immunity. Although most patients have mild flu-like symptoms, some develop severe illnesses accompanied by multiple organ dysfunction. The identification of pathophysiology and early warning biomarkers of a severe type of COVID-19 contribute to the treatment and prevention of serious complications. Here, we review the pathophysiology, early warning indicators, and effective treatment of Chinese and Western Medicine for patients with a severe type of COVID-19.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Chin J Integr Med Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Chin J Integr Med Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article País de afiliación: China